Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine contrast-enhanced ultrasound guidelines. Rare pancreatic tumors, imaging features on transabdominal ultrasound and EUS with contrast enhancement: Rare epithelial pancreatic tumors: solid pseudopapillary neoplasm, acinar cell carcinoma, mixed neuroendocrine-non-neuroendocrine neoplasms, some rare subtypes of pancreatic adenocarcinoma and pancreatoblastoma.

Moller, K.; Lowe, A.; Jenssen, C.; Bhutani, MS.; On, W.; Everett, SM.; Braden, B.; Hocke, M.; Healey, A.; Dong, Y.; Gerber, M.; Faiss, S.; Rimbas, M.; Ge, N.; Sun, S.; Taut, H.; Srivastava, D.; Burmester, E.; Dietrich, CF.

Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine contrast-enhanced ultrasound guidelines. Rare pancreatic tumors, imaging features on transabdominal ultrasound and EUS with contrast enhancement: Rare epithelial pancreatic tumors: solid pseudopapillary neoplasm, acinar cell carcinoma, mixed neuroendocrine-non-neuroendocrine neoplasms, some rare subtypes of pancreatic adenocarcinoma and pancreatoblastoma.

All Authors

Moller, K.

Lowe, A.

Jenssen, C.

Bhutani, MS.

On, W.

Everett, SM.

Braden, B.

Hocke, M.

Healey, A.

Dong, Y.

Show 9 more

LTHT Author

On, Wei
Everett, Simon

LTHT Department

Gastroenterology

Publication Date

2024

Item Type

Journal Article

Abstract

Rare malignant pancreatic lesions are systematically reported in this review. The focus is on the imaging appearance of the rare epithelial pancreatic tumors such as the solid pseudopapillary neoplasm, acinar cell carcinoma, rare subtypes of adenocarcinoma, and pancreatoblastoma as seen on ultrasound, EUS, and contrast-enhanced ultrasound or EUS. The present overview summarizes the data and shows that not every pancreatic tumor is likely to be the most common entities of ductal adenocarcinoma or neuroendocrine tumor.